PR Newswire - Henlius Receives Orphan Drug Designation for Innov...
SHANGHAI, March 19, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the co...
Read More

ภาษาไทย
English